- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02566291
Observational Study With Investigation of Two Second Generation Laryngeal Masks (OSSGA)
January 22, 2017 updated by: Marc Kriege, MD, Johannes Gutenberg University Mainz
Supraglottic Airways LMA Supreme and Ambu AuraGain in Clinical Practice: a Prospective Observational Study
In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.
Study Overview
Detailed Description
After approval from the local ethics committee, data were collected in a prospective, non- randomised study over a three-month period.
When contra-indications for laryngeal mask use were absent anaesthesiologists used either Supreme (Teleflex Medical GmbH, Germany) or Gain (Ambu GmbH, Germany).
Endpoints were the success rate and time to insertion.
Study Type
Observational
Enrollment (Actual)
364
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhineland-Palatinate
-
Mainz, Rhineland-Palatinate, Germany, D55131
- Department of Anaesthesiology;
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Inclusion criteria:
Age > 18 Years informed consent elective surgery undergoing general anesthesia non-pregnant
Description
Inclusion Criteria:
- Age ≥ 18 Years
- No concurrent participation in another study
- capacity to consent
- Present written informed consent of the research participant
- Elective surgery under general anesthesia
Exclusion Criteria:
- Age <18 years
- Existing pregnancy
- Lack of consent
- inability to consent
- emergency patients
- Emergency situations in the context of a Difficult Airway Management
- ASA classification> 3
- situations where the possibility of accumulated gastric contents
- Participation in another study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Supreme Group
Measuring Success rate and Insertion Time
|
Success rate and time for insertion
|
Gain Group
Measuring Success rate and Insertion Time
|
Success rate and time for insertion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success rate
Time Frame: 70-98 Percent
|
overall and first attempt success rate
|
70-98 Percent
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time for insertion
Time Frame: 5-120 seconds
|
5-120 seconds
|
Leakage in ml.min
Time Frame: 0-300 ml.min
|
0-300 ml.min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Marc MK Kriege, MD, University JG, Mainz
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2015
Primary Completion (Actual)
January 1, 2015
Study Completion (Actual)
March 1, 2015
Study Registration Dates
First Submitted
September 30, 2015
First Submitted That Met QC Criteria
October 1, 2015
First Posted (Estimate)
October 2, 2015
Study Record Updates
Last Update Posted (Estimate)
January 24, 2017
Last Update Submitted That Met QC Criteria
January 22, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SGA 2014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Airway Remodeling
-
Milton S. Hershey Medical CenterTerminatedAirway RemodelingUnited States
-
Guangzhou Institute of Respiratory DiseaseRecruiting
-
Sir Ganga Ram HospitalCompleted
-
University Hospital, MontpellierRecruiting
-
First Affiliated Hospital of Zhejiang UniversityZhejiang Provincial Tongde HospitalRecruitingAirway Remodeling | Position | Patency | Morphology | Radiography in OtolaryngologyChina
-
Institut National de la Santé Et de la Recherche...TerminatedEffect of Sitaxsentan on Airway Remodeling in Severe AsthmaFrance
-
NorthShore University HealthSystemRecruitingMedically Unexplained Symptoms | Airway Obstruction | Nasal Obstruction | Airway RemodelingUnited States
-
Lithuanian University of Health SciencesUniversity of Groningen; Research Council of LithuaniaCompleted
-
The First Affiliated Hospital of Guangzhou Medical...Enrolling by invitationRespiratory Disease | Bronchoscopy | Airway Remodeling | Tomography, Optical CoherenceChina
Clinical Trials on Success
-
University of Maryland, BaltimoreRecruiting
-
Medical Research Council, South AfricaCompletedPartner of Victim of Physical Abuse
-
Medtronic Cardiac Rhythm and Heart FailureCompletedHeart FailureUnited States, France, Poland, Taiwan, Malaysia, Romania, China, Puerto Rico, Thailand, India, Canada, Pakistan, Hong Kong, Germany, Malta, Singapore
-
Trustees of Dartmouth CollegeNot yet recruitingPain | Placebo EffectUnited States
-
Education Development Center, Inc.UnknownHIV | Sexually Transmitted Infections
-
Stanford UniversityCompletedAutism Spectrum DisorderUnited States
-
Sara Davin, PsyD, MPHCompleted
-
University of PittsburghOhio State University; Centers for Disease Control and Prevention; Case Western...Not yet recruiting
-
Johns Hopkins UniversityBrancati Center for the Advancement of Community Care; Center for Community... and other collaboratorsCompletedUncontrolled DiabetesUnited States
-
Harvard UniversityCompletedDepression | Stress | AnxietyUnited States